Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)

Clinical trial NCT00953121 · COMPLETED

Trial details

NCT number: NCT00953121
Sponsor: Annick Desjardins
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Glioma

Start date: 2009-09-01
Primary completion: 2012-07-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.